Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis
5/2/2012

California, Florida, Illinois, Kansas, Louisiana, Maryland, Massachusetts, Michigan, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Utah, Virginia, Australia, Canada, France, Germany, Greece, Hong Kong, Italy, Republic of Korea, Netherlands, Poland, Portugal, Romania, Singapore, Spain, Taiwan, Turkey, United Kingdom. clinicaltrials.gov

Related Summaries